SCIENCE NEWS Scientists First to Identify Wide Variety of Genetic Splicing in Embryonic Stem Cells Human embryonic stem cells must sort through a seemingly endless number of options to settle on the specific genetic message that instructs them to become more-specialized cells in the body. Researchers have shown that this tuning process is accomplished in part by restricting the number of transcripts produced from each gene. [Press release from the Stanford University School of Medicine discussing the online prepublication in the Proceedings of the National Academy of Sciences USA] Breakthrough Reveals Blood Vessel Cells Are Key to Growing Unlimited Amounts of Adult Stem Cells In a leap toward making stem cell therapy widely available, researchers have discovered that endothelial cells produce growth factors that can grow copious amounts of adult stem cells and their progeny over the course of weeks. [Press release from the Weill Cornell Medical College discussing the online prepublication in Cell Stem Cell] Deceptive Model They are considered to be the most important model organism for research into human biology: mice may look totally different, but they are in many ways similar to Homo sapiens on a fundamental level. [Press release from the Max Planck Institute for Molecular Biomedicine discussing the online prepublication in Cell Stem Cell] Theory of Single Stem Cell for Blood Components Challenged Components of the blood or hematopoietic system derive from stem cell subtypes rather than one single stem cell that give rise to all the different kinds of blood cells equally. [Press release from the Baylor College of Medicine discussing the online prepublication in Cell Stem Cell] ReNeuron Presents Key Pre-Clinical Efficacy Data with ReN009 Stem Cell Therapy at Leading United Kingdom Diabetes Conference ReNeuron Group plc announces further positive pre-clinical efficacy data with its ReN009 stem cell therapy for peripheral arterial disease in diabetic patients. [ReNeuron Group plc Press Release] Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies New findings suggest that patients who benefit from gene therapy in one eye may experience similar benefits from treatment in the other eye for Leber’s congenital amaurosis, a retinal disease that progresses to total blindness by adulthood. [Press release from the University of Pennsylvania School of Medicine discussing the online prepublication in Science Translational Medicine] Stem Cell Therapy Used for Urinary Incontinence Researchers at Vanderbilt University Medical Center are among three North American study sites to participate in a clinical trial using autologous adult stem cell transplantation to treat an exceedingly common problem in women — stress-related urinary incontinence. [Vanderbilt University Medical Center Press Release] Pluristem Therapeutics Receives Data Safety Monitoring Board Approval to Advance to Final Dose Level with PLX-PAD Pluristem Therapeutics Inc. recently announced that it has received approval from an independent Data Safety Monitoring Board to advance to the highest and final dose level with its placenta-derived cell therapy product, PLX-PAD, in a Phase I dose-escalating clinical trial in Europe for the treatment of critical limb ischemia, the end-stage of peripheral artery disease. [Pluristem Therapeutics Inc. Press Release] International Stem Cell Corporation Parthenogenetic Stem Cell Line Shown to Carry the Most Common Immune Genes Matched to the U.S. Population Retains Stem Cell Characteristics over Two Years in Culture, Which is Necessary for Therapeutic Value International Stem Cell Corporation announced that human parthenogenetic stem cell lines, created by scientists from its Research and Therapeutic Development Group, have demonstrated ability to maintain the essential properties of immortal stem cells throughout extended laboratory cultivation. [International Stem Cell Corporation Press Release] CURRENT PUBLICATIONS Reprogrammed Cells Come Up Short, for Now Recent research papers offer some of the first side-by-side comparisons of human induced pluripotent stem and human embryonic stem cells as they differentiate into various kinds of cells. [Science] Rescue of the Spinal Muscular Atrophy Phenotype in a Mouse Model by Early Postnatal Delivery of SMN Researchers use scAAV9-mediated postnatal day 1 vascular gene delivery to replace SMN in spinal muscular atrophy pups and rescue motor function, neuromuscular physiology and life span. [Nat Biotechnol] Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells Researchers developed angiogenic models to demonstrate that endothelial cell-derived angiocrine growth factors support in vitro self-renewal and in vivo repopulation of authentic long-term hematopoietic stem cells. [Cell Stem Cell] Conserved and Divergent Roles of Fibroblast Growth Factor 2 Signaling in Mouse Epiblast Stem Cells and Human Embryonic Stem Cells Investigators show that activation of the Activin pathway promotes self-renewal of epiblast stem cells via direct activation of Nanog, whereas inhibition of this pathway induces neuroectodermal differentiation, like in human embryonic stem cells. [Cell Stem Cell] Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by Transforming Growth Factor Beta 1 This study demonstrates definitive isolation of lineage-biased hematopoietic stem cells subtypes and contributes to the fundamental change in view that the hematopoietic system is maintained by a continuum of hematopoietic stem cells subtypes, rather than a functionally uniform pool. [Cell Stem Cell] Dynamic Transcriptomes During Neural Differentiation of Human Embryonic Stem Cells Revealed by Short, Long, and Paired-End Sequencing To examine the fundamental mechanisms governing neural differentiation, researchers analyzed the transcriptome changes that occur during the differentiation of human embryonic stem cells into the neural lineage. [Proc Natl Acad Sci U S A] Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness Researchers evaluated the immunological and functional consequences of readministration of rAAV2-hRPE65v2 to the contralateral eye using large animal models. [Sci Transl Med]
|